Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Merli

Showing results (61-70 of 216) with videos related to

Pageof 22
Sort By:
Journal of Clinical and Experimental Hepatology|September 11, 2023
New Indications for TIPSs: What Do We Know So Far?Lucia Lapenna, Simone Di Cola, Jakub Gazda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2019
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPSStefania Gioia, Manuela Merli, Silvia Nardelli, et al.
Journal of Clinical and Experimental Hepatology|September 26, 2022
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infections in Patients With Liver CirrhosisShani Feldman, Alessandro Russo, Giancarlo Ceccarelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2021
The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shuntStefania Gioia, Lorenzo Ridola, Ludovica Cristofaro, et al.
Hepatology (Baltimore, Md.)|May 1, 2019
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver CirrhosisSilvia Nardelli, Barbara Lattanzi, Manuela Merli, et al.
Clinical Drug Investigation|February 17, 2010
Atorvastatin-induced prolonged cholestasis with bile duct damageManuela Merli, Maria Consiglia Bragazzi, Federica Giubilo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathyOliviero Riggio, Lorenzo Ridola, Chiara Pasquale, et al.
The Australasian Journal of Dermatology|February 26, 2021
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case reportAntonio Richetta, Federica Marraffa, Sara Grassi, et al.
World Journal of Gastroenterology|October 7, 2008
Accuracy of the automated cell counters for management of spontaneous bacterial peritonitisOliviero Riggio, Stefania Angeloni, Antonella Parente, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patientsFederica Moscucci, Silvia Nardelli, Ilaria Pentassuglio, et al.
Pageof 22

Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Journal of Clinical and Experimental Hepatology|September 11, 2023
New Indications for TIPSs: What Do We Know So Far?Lucia Lapenna, Simone Di Cola, Jakub Gazda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2019
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPSStefania Gioia, Manuela Merli, Silvia Nardelli, et al.
Journal of Clinical and Experimental Hepatology|September 26, 2022
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infections in Patients With Liver CirrhosisShani Feldman, Alessandro Russo, Giancarlo Ceccarelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2021
The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shuntStefania Gioia, Lorenzo Ridola, Ludovica Cristofaro, et al.
Hepatology (Baltimore, Md.)|May 1, 2019
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver CirrhosisSilvia Nardelli, Barbara Lattanzi, Manuela Merli, et al.
Clinical Drug Investigation|February 17, 2010
Atorvastatin-induced prolonged cholestasis with bile duct damageManuela Merli, Maria Consiglia Bragazzi, Federica Giubilo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathyOliviero Riggio, Lorenzo Ridola, Chiara Pasquale, et al.
The Australasian Journal of Dermatology|February 26, 2021
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case reportAntonio Richetta, Federica Marraffa, Sara Grassi, et al.
World Journal of Gastroenterology|October 7, 2008
Accuracy of the automated cell counters for management of spontaneous bacterial peritonitisOliviero Riggio, Stefania Angeloni, Antonella Parente, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patientsFederica Moscucci, Silvia Nardelli, Ilaria Pentassuglio, et al.
Pageof 22